4 Stories

Maker Pulls Weight-Loss Drug

Company disagrees with regulators' assessment of an increased risk of cancer

(Newser) - The maker of a weight loss drug pulled it from the market Thursday at the request of federal regulators, who said it posed an increased risk of cancer. Japan's Eisai said it was voluntarily withdrawing the drug, Belviq, the AP reports. However, the company said in a statement that...

FDA Greenlights 2nd Weight-Loss Drug

Qsymia the more effective of the pair in clinical trials

(Newser) - After 13 years without approving a new weight-loss drug, the FDA has now approved two within three weeks. After June's approval of Belviq , the FDA yesterday approved Qsymia, which used to be called Qnexa ; both drugs had previously been rejected. In studies, Qsymia resulted in the greater weight loss:...

Why I'm Wary of the New Weight-Loss Drug Belviq

Lindsay Beyerstein fears it's being viewed as the next fen-phen

(Newser) - The FDA has green-lighted the first new prescription weight-loss drug in 13 years—and Lindsay Beyerstein isn't exactly tossing confetti into the air at the news. Writing for Slate , she asserts that Belviq is no wonder drug: In trials, patients lost about 3% of their initial body weight, which...

FDA OKs First Diet Pill in 13 Years

Arena's Belviq is intended for the obese

(Newser) - For the first time in 13 years, the FDA has approved an anti-obesity pill. The medication, called Belviq, targets a section of the brain responsible for regulating hunger, reports Bloomberg . Sales could hit $2 billion in 2020, predicts an analyst. “Two-thirds of the people in this country are overweight...

4 Stories
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.